In addition, p15INK4b promoter methylation has been found in 65% of head and neck squamous cell carcinoma [11], 47% of hepatocellular carcinoma [12], 36% of T-cell lymphoma [31] and 30% of ovarian cancer [20]. Here, CDKN2B is linked to hepatocellular carcinoma.